S&P 500   4,281.40 (-0.16%)
DOW   33,415.11 (-0.28%)
QQQ   359.41 (+0.32%)
AAPL   173.09 (+1.10%)
MSFT   318.88 (+0.99%)
META   304.51 (+1.43%)
GOOGL   133.08 (+1.70%)
AMZN   128.93 (+1.42%)
TSLA   248.80 (-0.57%)
NVDA   446.52 (+2.65%)
NIO   8.76 (-3.10%)
BABA   86.13 (-0.70%)
AMD   102.57 (-0.24%)
T   14.72 (-2.00%)
F   12.27 (-1.21%)
MU   67.70 (-0.49%)
CGC   0.73 (-7.31%)
GE   108.55 (-1.81%)
DIS   81.31 (+0.32%)
AMC   8.02 (+0.38%)
PFE   33.66 (+1.48%)
PYPL   58.43 (-0.05%)
NFLX   379.21 (+0.43%)
S&P 500   4,281.40 (-0.16%)
DOW   33,415.11 (-0.28%)
QQQ   359.41 (+0.32%)
AAPL   173.09 (+1.10%)
MSFT   318.88 (+0.99%)
META   304.51 (+1.43%)
GOOGL   133.08 (+1.70%)
AMZN   128.93 (+1.42%)
TSLA   248.80 (-0.57%)
NVDA   446.52 (+2.65%)
NIO   8.76 (-3.10%)
BABA   86.13 (-0.70%)
AMD   102.57 (-0.24%)
T   14.72 (-2.00%)
F   12.27 (-1.21%)
MU   67.70 (-0.49%)
CGC   0.73 (-7.31%)
GE   108.55 (-1.81%)
DIS   81.31 (+0.32%)
AMC   8.02 (+0.38%)
PFE   33.66 (+1.48%)
PYPL   58.43 (-0.05%)
NFLX   379.21 (+0.43%)
S&P 500   4,281.40 (-0.16%)
DOW   33,415.11 (-0.28%)
QQQ   359.41 (+0.32%)
AAPL   173.09 (+1.10%)
MSFT   318.88 (+0.99%)
META   304.51 (+1.43%)
GOOGL   133.08 (+1.70%)
AMZN   128.93 (+1.42%)
TSLA   248.80 (-0.57%)
NVDA   446.52 (+2.65%)
NIO   8.76 (-3.10%)
BABA   86.13 (-0.70%)
AMD   102.57 (-0.24%)
T   14.72 (-2.00%)
F   12.27 (-1.21%)
MU   67.70 (-0.49%)
CGC   0.73 (-7.31%)
GE   108.55 (-1.81%)
DIS   81.31 (+0.32%)
AMC   8.02 (+0.38%)
PFE   33.66 (+1.48%)
PYPL   58.43 (-0.05%)
NFLX   379.21 (+0.43%)
S&P 500   4,281.40 (-0.16%)
DOW   33,415.11 (-0.28%)
QQQ   359.41 (+0.32%)
AAPL   173.09 (+1.10%)
MSFT   318.88 (+0.99%)
META   304.51 (+1.43%)
GOOGL   133.08 (+1.70%)
AMZN   128.93 (+1.42%)
TSLA   248.80 (-0.57%)
NVDA   446.52 (+2.65%)
NIO   8.76 (-3.10%)
BABA   86.13 (-0.70%)
AMD   102.57 (-0.24%)
T   14.72 (-2.00%)
F   12.27 (-1.21%)
MU   67.70 (-0.49%)
CGC   0.73 (-7.31%)
GE   108.55 (-1.81%)
DIS   81.31 (+0.32%)
AMC   8.02 (+0.38%)
PFE   33.66 (+1.48%)
PYPL   58.43 (-0.05%)
NFLX   379.21 (+0.43%)
NASDAQ:AHCO

AdaptHealth (AHCO) Price Target & Analyst Ratings

$8.99
-0.11 (-1.21%)
(As of 01:56 PM ET)
Compare
Today's Range
$8.96
$9.10
50-Day Range
$8.60
$14.77
52-Week Range
$8.41
$23.30
Volume
359,747 shs
Average Volume
1.28 million shs
Market Capitalization
$1.22 billion
P/E Ratio
74.92
Dividend Yield
N/A
Price Target
$18.92

AdaptHealth Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Moderate Buy
Based on 7 Analyst Ratings

Consensus Analyst Price Target

$18.92
110.48% Upside
High Prediction$30.00
Average Prediction$18.92
Low Prediction$11.00
TypeCurrent
10/2/22 to 10/2/23
1 Month Ago
9/2/22 to 9/2/23
3 Months Ago
7/4/22 to 7/4/23
1 Year Ago
10/2/21 to 10/2/22
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
4 Buy rating(s)
4 Buy rating(s)
4 Buy rating(s)
5 Buy rating(s)
Hold
3 Hold rating(s)
3 Hold rating(s)
3 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$18.92$19.03$18.92$27.17
Predicted Upside110.48% Upside31.46% Upside31.51% Upside46.12% Upside
Get AdaptHealth Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for AHCO and its competitors with MarketBeat's FREE daily newsletter.


AHCO Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

AHCO Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

AdaptHealth Stock vs. The Competition

TypeAdaptHealthMedical CompaniesS&P 500
Consensus Rating Score
2.57
2.65
2.49
Consensus RatingModerate BuyModerate BuyHold
Predicted Upside110.01% Upside893.33% Upside698.25% Upside
News Sentiment RatingNeutral News
Positive News
Positive News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
9/22/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$13.00 ➝ $11.00+27.02%
7/13/2023Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$20.00 ➝ $21.00+64.84%
5/11/2023Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$24.00 ➝ $18.00+73.58%
5/10/2023Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$28.00 ➝ $11.30
5/9/2023Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$18.00 ➝ $11.00-2.65%
4/13/2023Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$20.00 ➝ $17.00+40.73%
3/1/2023SVB Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$30.00 ➝ $23.00+47.53%
11/10/2022SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Whit Mayo
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOutperform$29.00 ➝ $30.00+44.79%
11/9/2022Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Richard Close
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy ➝ Buy$26.00 ➝ $28.00+29.63%
(Data available from 10/2/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












AHCO Price Target - Frequently Asked Questions

What is AdaptHealth's consensus rating and price target?

According to the issued ratings of 7 analysts in the last year, the consensus rating for AdaptHealth stock is Moderate Buy based on the current 3 hold ratings and 4 buy ratings for AHCO. The average twelve-month price prediction for AdaptHealth is $18.92 with a high price target of $30.00 and a low price target of $11.00. Learn more on AHCO's analyst rating history.

Do Wall Street analysts like AdaptHealth more than its competitors?

Analysts like AdaptHealth less than other Medical companies. The consensus rating score for AdaptHealth is 2.57 while the average consensus rating score for medical companies is 2.66. Learn more on how AHCO compares to other companies.

Does AdaptHealth's stock price have much upside?

According to analysts, AdaptHealth's stock has a predicted upside of 33.96% based on their 12-month price targets.

What analysts cover AdaptHealth?

AdaptHealth has been rated by Bank of America, and Robert W. Baird in the past 90 days.


Stock Ratings Reports and Tools

This page (NASDAQ:AHCO) was last updated on 10/2/2023 by MarketBeat.com Staff

My Account -